News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
300,023 Results
Type
Article (14992)
Company Profile (293)
Press Release (284738)
Section
Business (91427)
Career Advice (156)
Deals (16129)
Drug Delivery (31)
Drug Development (53511)
Employer Resources (31)
FDA (6806)
Job Trends (5589)
News (164877)
Policy (12313)
Tag
Academia (950)
Alliances (25881)
Alzheimer's disease (773)
Approvals (6774)
Artificial intelligence (60)
Bankruptcy (103)
Best Places to Work (4759)
Biotechnology (243)
Breast cancer (58)
Cancer (593)
Cardiovascular disease (51)
Career advice (137)
Cell therapy (147)
Clinical research (42310)
Collaboration (210)
Compensation (80)
COVID-19 (1079)
C-suite (51)
Cystic fibrosis (61)
Data (622)
Diabetes (62)
Diagnostics (1627)
Earnings (32929)
Events (50356)
Executive appointments (153)
FDA (7070)
Funding (212)
Gene editing (46)
Gene therapy (126)
GLP-1 (305)
Government (1186)
Healthcare (7074)
Infectious disease (1111)
Inflammatory bowel disease (91)
IPO (7995)
Job creations (1038)
Job search strategy (133)
Layoffs (187)
Legal (2120)
Lung cancer (107)
Manufacturing (71)
Medical device (3469)
Medtech (3471)
Mergers & acquisitions (8215)
Metabolic disorders (198)
Neuroscience (954)
NextGen Class of 2024 (2113)
Non-profit (883)
Northern California (780)
Obesity (115)
Opinion (89)
Parkinson's disease (55)
Patents (47)
People (27439)
Pharmaceutical (47)
Phase I (14543)
Phase II (19475)
Phase III (12792)
Pipeline (143)
Postmarket research (986)
Preclinical (6101)
Radiopharmaceuticals (210)
Rare diseases (143)
Real estate (1863)
Regulatory (9631)
Research institute (974)
Southern California (714)
Startups (2169)
United States (6659)
Vaccines (162)
Weight loss (69)
Date
Last 7 days (493)
Last 30 days (1725)
Last 365 days (22010)
2024 (18630)
2023 (23986)
2022 (30278)
2021 (31176)
2020 (26639)
2019 (18411)
2018 (13484)
2017 (15659)
2016 (13766)
2015 (16838)
2014 (12489)
2013 (9344)
2012 (9561)
2011 (9737)
2010 (9327)
Location
Africa (195)
Arizona (45)
Asia (29483)
Australia (4260)
California (1765)
Canada (696)
China (152)
Colorado (62)
Connecticut (70)
Europe (43404)
Florida (190)
Georgia (51)
Illinois (112)
Indiana (50)
Kansas (58)
Maryland (270)
Massachusetts (1494)
Michigan (45)
Minnesota (98)
New Jersey (499)
New York (548)
North Carolina (390)
Northern California (780)
Ohio (69)
Pennsylvania (377)
South America (273)
Southern California (714)
Texas (179)
Washington State (193)
300,023 Results for "tessa therapeutics pte ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
BioSkryb Genomics Partners with Research Instruments Pte Ltd to Bring Industry Leading Single-Cell Technologies to Singapore and Southeast Asia
BioSkryb Genomics announced a partnership with Research Instruments Pte Ltd, a premier distributor for genomic and life science research products in Southeast Asia, to distribute BioSkryb’s ResolveDNA® and ResolveOME™ single cell amplification tools throughout Singapore and Southeast Asia.
August 29, 2023
·
4 min read
Biotech Bay
ValGenesis and Radiant Digital PTE Ltd. Partner to Enable Digital Transformation Across Life Sciences in Singapore
ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems, and Radiant Digital PTE Ltd. a provider of digital transformation delivery services to commercial and government clients, have partnered to facilitate the digital transformation of life sciences companies in Singapore.
June 20, 2023
·
3 min read
Tessa Therapeutics Enters into Cooperative Research and Development Agreement (CRADA) with the U.S. National Cancer Institute
Tessa Therapeutics Ltd. announced entry into a Cooperative Research and Development Agreement with the U.S. National Cancer Institute, part of the National Institutes of Health, to investigate TT11X, Tessa’s allogeneic “off-the-shelf” CD30.CAR-modified Epstein-Barr virus-specific T-cell therapy, in multiple subtypes of non-Hodgkin lymphoma.
March 8, 2023
·
5 min read
Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma
Tessa Therapeutics Ltd., a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, announced promising safety and efficacy data from a study of its off-the-shelf CD30.CAR EBVST therapy in patients with relapsed or refractory Hodgkin lymphoma.
June 15, 2023
·
6 min read
Press Releases
SEED Therapeutics Appoints Eisai Co., Ltd.’s Dr. Yoshiharu Mizui to Board of Directors
September 12, 2024
·
2 min read
Tessa Therapeutics’ Autologous and Allogeneic Cell Therapy Data to be Featured at the 17th International Conference on Malignant Lymphoma, Lugano
Tessa Therapeutics Ltd. announced two presentations featuring clinical data from the company’s autologous CD30.CAR-T therapy TT11 and off-the-shelf CD30 CAR EBVST therapy will be featured at the 17th International Conference on Malignant Lymphoma taking place from June 13-17, 2023, at Lugano, Switzerland.
May 30, 2023
·
4 min read
Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023
Tessa Therapeutics Ltd. announced that the company will prioritize development of its allogeneic “off-the-shelf” CD30.CAR-modified Epstein-Barr virus-specific T-cell therapy platform, while seeking strategic options for the development of its TT11 autologous CAR-T platform with other companies.
January 3, 2023
·
5 min read
Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics
Hyphens Pharma International Limited is pleased to announce that its subsidiary, Hyphens Pharma Pte. Ltd., has entered into an exclusive license, supply and commercialisation agreement with MC2 Therapeutics for the exclusive rights to register and commercialise Wynzora® Cream and all future product extensions and/or improvements for the topical treatment of plaque psoriasis in the 10 ASEAN countries.
March 12, 2024
·
5 min read
Press Releases
Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies
October 30, 2024
·
5 min read
Tessa Therapeutics to Present at the Stifel Healthcare Conference 2022
Tessa Therapeutics Ltd., a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, announced that Thomas Willemsen, President and CEO, and Dr. Ivan D. Horak, Chief Medical Officer and Chief Scientific Officer, will present at the Stifel Healthcare Conference 2022.
November 2, 2022
·
3 min read
1 of 30,003
Next